These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8808744)

  • 1. Emerging fungal infections in cancer patients.
    Krcmery V
    J Hosp Infect; 1996 Jun; 33(2):109-17. PubMed ID: 8808744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management.
    Vartivarian SE; Anaissie EJ; Bodey GP
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S487-91. PubMed ID: 8274615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in cancer patients: an escalating problem.
    Samonis G; Bafaloukos D
    In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer treatments for fungal infections.
    Knapp KM; Flynn PM
    J Support Oncol; 2005; 3(4):290-8. PubMed ID: 16092600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():89-94. PubMed ID: 15686055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and therapy of fungal infections in cancer patients. A review of recently published information.
    Klastersky J
    Support Care Cancer; 1995 Nov; 3(6):393-401. PubMed ID: 8564343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic fungal infections in neonates.
    Ng PC
    Arch Dis Child Fetal Neonatal Ed; 1994 Sep; 71(2):F130-5. PubMed ID: 7979469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging fungal threat.
    Sternberg S
    Science; 1994 Dec; 266(5191):1632-4. PubMed ID: 7702654
    [No Abstract]   [Full Text] [Related]  

  • 11. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
    Perlroth J; Choi B; Spellberg B
    Med Mycol; 2007 Jun; 45(4):321-46. PubMed ID: 17510856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
    Salonen JH; Richardson MD; Gallacher K; Issakainen J; Helenius H; Lehtonen OP; Nikoskelainen J
    J Hosp Infect; 2000 Aug; 45(4):293-301. PubMed ID: 10973747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal prophylaxis in immunocompromised hosts.
    Reents S; Goodwin SD; Singh V
    Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy.
    Hof H
    Mycoses; 2008; 51 Suppl 1():1-6. PubMed ID: 18471155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.